Therapeutic Plasma Exchange in Pediatric Kidney Disease: 23-year Experience at the Severance Children’s Hospital in Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The American Society for Apheresis provides clinical guidelines for therapeutic apheresis in adults, but there are no guidelines for children. This study aimed to analyze the effect of therapeutic plasma exchange (TPE) in pediatric patients with various kidney diseases in Korea. Methods: We retrospectively reviewed the data of 16 children (up to 18 years of age) who were admitted to Severance Children’s Hospital with refractory kidney disease. All patients received TPE between 1994 and 2016. Clinical and laboratory characteristics such as age, weight, sex, change in blood urea nitrogen (BUN), and creatinine level before and after TPE, and complications after TPE were analyzed. Results: The mean age and weight of the 16 patients at the time of TPE was 11.3± 4.0 years and 34.6±17.5 kg, respectively. The BUN level was 35.4 mg/dL before TPE and significantly decreased to 21.5 mg/dL (P =0.025) at 1 week and 20.5 mg/dL (P = 0.01) at 1 month after TPE. The creatinine level significantly decreased from 1.20 mg/dL before TPE to 0.90 mg/dL (P=0.02) at 1 week after TPE. Four complications (hypovolemia, anemia, hypocalcemia, and thrombocytopenia) were reported, but were not fatal. Conclusion: Our findings suggest that TPE is an effective therapeutic modality in children with refractory kidney disease and can be indicated for the treatment of various kidney diseases.
Abstract
Purpose: The American Society for Apheresis provides clinical guidelines for therapeutic apheresis in adults, but there are no guidelines for children. This study aimed to analyze the effect of therapeutic plasma exchange (TPE) in pediatric patients with various kidney diseases in Korea. Methods: We retrospectively reviewed the data of 16 children (up to 18 years of age) who were admitted to Severance Children’s Hospital with refractory kidney disease. All patients received TPE between 1994 and 2016. Clinical and laboratory characteristics such as age, weight, sex, change in blood urea nitrogen (BUN), and creatinine level before and after TPE, and complications after TPE were analyzed. Results: The mean age and weight of the 16 patients at the time of TPE was 11.3± 4.0 years and 34.6±17.5 kg, respectively. The BUN level was 35.4 mg/dL before TPE and significantly decreased to 21.5 mg/dL (P =0.025) at 1 week and 20.5 mg/dL (P = 0.01) at 1 month after TPE. The creatinine level significantly decreased from 1.20 mg/dL before TPE to 0.90 mg/dL (P=0.02) at 1 week after TPE. Four complications (hypovolemia, anemia, hypocalcemia, and thrombocytopenia) were reported, but were not fatal. Conclusion: Our findings suggest that TPE is an effective therapeutic modality in children with refractory kidney disease and can be indicated for the treatment of various kidney diseases.
참고문헌 (26)
- Ward DM, "Conventional apheresis therapies: a review", J Clin Apher, 26, pp.230~238 (2011)
- Baweja S, "Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach", J Artif Organs, 14, pp.9~22 (2011)
- Carter CE, "Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013", Pediatr Nephrol, 29, pp.35~50 (2014)
- Abel JJ, "Plasma removal with return of corpuscles (plasmaphaeresis). The Journal of Pharmacology and experimental therapeutics Vol. V. No. 6, July, 1914", Transfus Sci, 11, pp.166~177 (1990)
- Schwab PJ, "Treatment of Waldenstrom's macroglobulinemia by plasmapheresis", N Engl J Med, 263, pp.574~579 (1960)
- Schwartz J, "Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis:The Seventh Special Issue", J Clin Apher, 31, pp.149~162 (2016)
- Cleper R, "Focal segmental glomerulosclerosis in pediatric kidney transplantation:30 years' experience", Clin Transplant, 30, pp.1324~1331 (2016)
- Paglialonga F, "Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units", Pediatr Nephrol, 30, pp.103~111 (2015)
- 임대균, "Plasmaphresis therapy for pulmonary hemorrhage in a pediatric patient with IgA nephropathy", Korean Journal of Pediatrics, 58(10), pp.402~405 (2015), 대한소아과학회
- 이지현, "소아에서 시행한 치료적 혈장교환술 9례의 임상적 고찰", Childhood Kidney Diseases, 9(1), pp.38~45 (2005), 대한소아신장학회
- Song KS, "Therapeutic Plasma Exchange (9 Cases)", Korean J Clin Pathol, 3, pp.11~15 (1983)
- Kim HO, "An Evaluation of 28 Cases of Therapeutic Plasma Exchange", Korean J Clin Pathol, 8, pp.459~467 (1988)
- Song EY, "Current status of therapeutic plasma exchange in Korea", Ther Apher Dial, 8, pp.97~101 (2004)
- Witt V, "World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry", Transfus Apher Sci, 39, pp.255~260 (2008)
- Reddy SK, "Plasma exchange for paediatric kidney disease-indications and outcomes: a singlecentre experience", Clin Kidney J, 8, pp.702~707 (2015)
- Blum D, "Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy", World J Nephrol, 4, pp.528~531 (2015)
- Li QY, "Plasmapheresis is associated with better renal outcomes in Lupus Nephritis patients with thrombotic microangiopathy", Medicine, 95, pp.1~10 (2016)
- Ponticelli C, "Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation", Nephrol Dial Transplant, 25, pp.25~31 (2010)
- Straatmann C, "Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients", Pediatr Transplant, 18, pp.29~34 (2014)
- Kara A, "Complications of therapeutic apheresis in children", Transfus Apher Sci, 48, pp.375~376 (2013)
- Weiss PF, "Pediatric therapeutic plasma exchange indications and patterns of use in US children's hospitals", J Clin Apher, 27, pp.287~294 (2012)
- 최계령, "치료적 혈장교환술에 사용하는 치환용액의 선택과 주의사항", 대한수혈학회지, 26(1), pp.9~17 (2015), 대한수혈학회[DOI]
- Basic-Jukic N, "Complications of therapeutic plasma exchange:experience with 4857 treatments", Ther Apher Dial, 9, pp.391~395 (2005)
- Misanovic V, "Plasmapheresis in Pediatric Intensive Care Unit", Med Arch, 70, pp.332~335 (2016)
- Szczepiorkowski ZM, "Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis", J Clin Apher, 22, pp.106~175 (2007)
- Szczepiorkowski ZM, "Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis", J Clin Apher, 25, pp.83~177 (2010)